U.S. publicly traded company Helius completes $500 million private financing to transform into SOL Treasury Co., with Pantera Capital and Summer Capital leading the investment

BlockBeats News, September 15th, according to stocktitan, Helius Medical Technologies (NASDAQ: HSDT) announced a significant strategic transformation, transitioning to a SOL Treasury company through a over $500 million private investment. This PIPE (Private Investment in Public Equity), led by Pantera Capital and Summer Capital, has been oversubscribed, involving the sale of common stock at $6.881 per share and accompanying warrants at $10.134 per unit, with a potential raise of over $1.25 billion when all warrants are exercised.

The company will use the raised funds to implement a digital asset treasury strategy, focusing on acquiring Solana's native cryptocurrency SOL as its primary reserve asset. This initiative leverages Solana's position as the fastest-growing blockchain.

The transaction is expected to be completed around September 18, 2025, with the newly appointed leadership team including Joseph Chee as Director and CEO, Cosmo Jiang as a Board Observer, and Dan Morehead as a Strategic Advisor.